crax: a simple cardiovascular risk assessment tool to predict risk of acute myocardial infarction or death

Determining the risk of cardiovascular events is essential to optimize patient management. 5842 individuals underwent spect myocardial perfusion imaging (mpi) with 4.4 ± 1.2 years of follow-up. models (the crax tool) were derived to predict the cumulative risk of death and acute myocardial infarction (ami) at 1, 3, and 5 years using clinical and mpi variables. predictors of ami and death included age, number of hospitalizations in the 3 years preceding mpi, and left ventricular ejection fraction (lvef). additional predictors of death were the use of pharmacological stress, and global stress total perfusion deficit (stpd), while transient ischemic dilation (tid), and ischemic total perfusion deficit (itpd) change were predictive of ami. crax predictions were significantly (p < .001) more accurate than clinical variables or mpi results alone, resulting in a significant net reclassification improvement (nri, 7.5% for ami, 14.5% death) compared to clinical variables alone. accuracy for predicting major adverse cardiac events (mace, comprising all-cause death, ami, unstable angina, late revascularization) was comparable to that of ami or death. crax is a risk assessment tool that predicts the risk of ami, death, or mace, and improves prediction compared to clinical variables or mpi results alone.